REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction | MicrobiomeTrials← Back to trialsNCT07876882
REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-24Est. Completion: 2027-12-24
Enrollment target: 250 participants Locations- Rheumatology Associates of Delmarva, Easton, Maryland, United States
- Rheumatology Associates of Delmarva, Salisbury, Maryland, United States
Other microbiome trials you might be interested in
SLESLE (Systemic Lupus)
Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Ery…
Avondale, United StatesEst. completion Dec 2026
Rheumatoid Arthritis (RAOsteoporosisOsteoarthritisInterstitial Lung DiseaseThyroid DiseasesCardiovascular DiseasesPulmonary ComplicationsSjogren's Syndrome
Liver Disorders
Renal Lesions
Vasculitis
Amyloidosis
Peripheral Neuropathy
Thrombosis
RA Complications
Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoim…
Beijing, ChinaCompleted Jan 31, 2026
Tumor Induced OsteomalciaOsteomalaciaFamilial Tumoral Calcinosis
This study has four objectives: 1) to provide investigators the opportunity to study bone specimens from patients with v…
Bethesda, United States